|
|
||||||||
1 Department of Physiology, Institute for Medical Sciences, Jeonbug National University Medical School, Jeonju 561-180; and 2 Department of Physiology, College of Oriental Medicine, Wonkwang University Medicinal Resources Research Center, Iksan 570-749, Korea
Regulation of atrial release of
atrial natriuretic peptide (ANP) is coupled to changes in atrial
dynamics. However, the mechanism by which mechanical stretch controls
myocytic ANP release must be defined. The purpose of this study was to
define the mechanism by which cAMP controls myocytic ANP release in
perfused, beating rabbit atria. The cAMP-elevating agents forskolin and
3-isobutyl-1-methylxanthine (IBMX) inhibited myocytic ANP release. The
activation of adenylyl cyclase with forskolin inhibited ANP release,
which was a function of an increase in cAMP production. Inhibitors for
L-type Ca2+ channels and protein kinase A (PKA) attenuated
a minor portion of the forskolin-induced inhibition of ANP release.
Gö-6976 and KN-62, which are specific inhibitors for protein
kinase C-
and Ca2+/calmodulin kinase, respectively,
failed to modulate forskolin-induced inhibition of ANP release. The
nonspecific protein kinase inhibitor staurosporine blocked
forskolin-induced inhibition of ANP release in a dose-dependent manner.
Staurosporine but not nifedipine shifted the relationship between cAMP
and ANP release. Inhibitors for L-type Ca2+ channels and
PKA and staurosporine blocked forskolin-induced accentuation of atrial
dynamics. These results suggest that cAMP inhibits atrial myocytic
release of ANP via protein kinase-dependent and L-type
Ca2+-channel-dependent and -independent signaling pathways.
atrial natriuretic peptide; forskolin; phosphodiesterase; channels
This article has been cited by other articles:
![]() |
K. Yuan, C. Cao, J. H. Han, S. Z. Kim, and S. H. Kim Adenosine-Stimulated Atrial Natriuretic Peptide Release Through A1 Receptor Subtype Hypertension, December 1, 2005; 46(6): 1381 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Jin, J. F. Wen, D. Li, and K. W. Cho Osmoregulation of atrial myocytic ANP release: osmotransduction via cross-talk between L-type Ca2+ channel and SR Ca2+ release Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1101 - R1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Luchner and H Schunkert Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system Cardiovasc Res, August 15, 2004; 63(3): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, J. F. Wen, J. Y. Jin, H. Jin, H. S. Ann, S. Z. Kim, S. H. Kim, H. S. Lee, and K. W. Cho Histamine inhibits atrial myocytic ANP release via H2 receptor-cAMP-protein kinase signaling Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R380 - R393. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |